A few years ago, a startup was charging people tens of thousands of dollars to infuse them with plasma from young donors. The FDA eventually issued a statement:
Open →In 2026, NMN entered its first clinical trial for autoimmune disease and appeared in Nature Medicine. Combined with new evidence on T cell senescence reversal and exercise-driven SIRT1 activation, three studies map NAD+ as an immune calibrator.
Open →There's a contradiction sitting at the center of anti-aging biology that doesn't get explained enough: some researchers are working hard to increase autophagy
Open →Mechanical ventilation is one of modern medicine's most important life-saving tools. For patients in respiratory failure, it is the bridge between death and sur
Open →That impressive AI agent demo you saw on Twitter? It probably falls apart in three minutes of real-world use. Not because the model is weak — because nobody bui
Open →